Kairos Pharma KAPA
NYSE KAPA
$0.54 -0.06 (-10.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Kairos Pharma (KAPA) Accumulated Expenses (2023)

Updated

Kairos Pharma's Accumulated Expenses came in at $43,000 for Q4 2023.

Analysis

Kairos Pharma (KAPA) Accumulated Expenses (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Kairos Pharma 11.24 Mn -1.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 43,000.00
API Access

Kairos Pharma Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KAPA&period=max&api_key=YOUR_API_KEY